热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　中国中药（00570）私有化后持续阴跌，今日早盘反弹逾8%，截至发稿，股价上涨6.31%，现报2.36港元，成交额2.37亿港元。

　　中国中药今年10月中旬宣布，国药集团共裕按每股4.6港元将公司私有化的先决条件仍未得到满足，建议于10月18日失效。据悉，今年2月，中国中药发布公告称，国药集团拟以每股4.6港元的价格将中国中药私有化。对于此次私有化的原因，中国中药认为由于二级市场的交易量有限，其作为上市公司融资平台功能存在受限。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.